Astrana Health [ASTH] vs Ardent Health [ARDT] Detailed Stock Comparison

Astrana Health

Ardent Health
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Astrana Health wins in 4 metrics, Ardent Health wins in 14 metrics, with 0 ties. Ardent Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Astrana Health | Ardent Health | Better |
---|---|---|---|
P/E Ratio (TTM) | 55.29 | 7.42 | Ardent Health |
Price-to-Book Ratio | 1.85 | 1.60 | Ardent Health |
Debt-to-Equity Ratio | 83.20 | 138.17 | Astrana Health |
PEG Ratio | -1.05 | 0.10 | Astrana Health |
EV/EBITDA | 13.24 | 7.08 | Ardent Health |
Profit Margin (TTM) | 1.04% | 4.11% | Ardent Health |
Operating Margin (TTM) | 3.11% | 8.34% | Ardent Health |
EBITDA Margin (TTM) | 3.11% | 8.34% | Ardent Health |
Return on Equity | 5.44% | 24.32% | Ardent Health |
Return on Assets (TTM) | 3.25% | 5.61% | Ardent Health |
Free Cash Flow (TTM) | $44.17M | $127.52M | Ardent Health |
1-Year Return | -48.66% | -23.97% | Ardent Health |
Price-to-Sales Ratio (TTM) | 0.55 | 0.32 | Ardent Health |
Enterprise Value | $1.31B | $4.12B | Ardent Health |
EV/Revenue Ratio | 0.54 | 0.67 | Astrana Health |
Gross Profit Margin (TTM) | 11.91% | 83.55% | Ardent Health |
Revenue per Share (TTM) | $50 | $44 | Astrana Health |
Earnings per Share (Diluted) | $0.52 | $1.89 | Ardent Health |
Beta (Stock Volatility) | 0.81 | N/A | N/A |
Astrana Health vs Ardent Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Astrana Health | 0.42% | -0.38% | -2.17% | 19.54% | -1.43% | -10.34% |
Ardent Health | 2.71% | 8.52% | 6.67% | 8.27% | 19.40% | -14.54% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Astrana Health | -48.66% | -8.35% | 57.93% | 340.76% | 466.08% | 466.08% |
Ardent Health | -23.97% | -16.59% | -16.59% | -16.59% | -16.59% | -16.59% |
News Based Sentiment: Astrana Health vs Ardent Health
Astrana Health
News based Sentiment: POSITIVE
Astrana Health reported strong financial performance with significant revenue and EPS growth, coupled with a very positive analyst outlook and a substantial potential upside. This combination of factors makes it a noteworthy development for investors.
Ardent Health
News based Sentiment: MIXED
Ardent Health experienced a slight stock decline in October, but also showed significant improvement in its Return on Capital Employed (ROCE) and appointed a new COO. These mixed signals create a balanced investment narrative, suggesting both potential and risk.
Performance & Financial Health Analysis: Astrana Health vs Ardent Health
Metric | ASTH | ARDT |
---|---|---|
Market Information | ||
Market Cap | $1.39B | $2.01B |
Market Cap Category | Small cap | Mid cap |
10 Day Avg. Volume | 324,610 | 336,040 |
90 Day Avg. Volume | 348,273 | 381,800 |
Last Close | $28.87 | $14.40 |
52 Week Range | $21.20 - $63.20 | $10.10 - $20.72 |
% from 52W High | -54.32% | -30.50% |
All-Time High | $133.23 (Nov 15, 2021) | $20.72 (Oct 14, 2024) |
% from All-Time High | -78.33% | -30.50% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.35% | 0.12% |
Quarterly Earnings Growth | -0.51% | 0.71% |
Financial Health | ||
Profit Margin (TTM) | 0.01% | 0.04% |
Operating Margin (TTM) | 0.03% | 0.08% |
Return on Equity (TTM) | 0.05% | 0.24% |
Debt to Equity (MRQ) | 83.20 | 138.17 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $15.58 | $8.77 |
Cash per Share (MRQ) | $6.85 | $3.83 |
Operating Cash Flow (TTM) | $130.56M | $301.98M |
Levered Free Cash Flow (TTM) | $97.63M | $19.78M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Astrana Health vs Ardent Health
Metric | ASTH | ARDT |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 55.29 | 7.42 |
Forward P/E | 18.79 | 7.01 |
PEG Ratio | -1.05 | 0.10 |
Price to Sales (TTM) | 0.55 | 0.32 |
Price to Book (MRQ) | 1.85 | 1.60 |
Market Capitalization | ||
Market Capitalization | $1.39B | $2.01B |
Enterprise Value | $1.31B | $4.12B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.54 | 0.67 |
Enterprise to EBITDA | 13.24 | 7.08 |
Risk & Other Metrics | ||
Beta | 0.81 | N/A |
Book Value per Share (MRQ) | $15.58 | $8.77 |
Financial Statements Comparison: Astrana Health vs Ardent Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ASTH | ARDT |
---|---|---|
Revenue/Sales | $654.81M | $1.50B |
Cost of Goods Sold | $576.84M | $258.86M |
Gross Profit | $77.97M | $1.24B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $20.34M | $67.09M |
EBITDA | $31.10M | $124.58M |
Pre-Tax Income | $16.83M | $74.20M |
Income Tax | $6.61M | $15.23M |
Net Income (Profit) | $10.22M | $58.97M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ASTH | ARDT |
---|---|---|
Cash & Equivalents | $258.52M | $495.04M |
Total Current Assets | $613.27M | $1.76B |
Total Current Liabilities | $361.27M | $830.14M |
Long-Term Debt | $433.40M | $2.26B |
Total Shareholders Equity | $517.71M | $1.56B |
Retained Earnings | $292.88M | $407.18M |
Property, Plant & Equipment | $47.55M | $2.06B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ASTH | ARDT |
---|---|---|
Operating Cash Flow | $12.67M | $21.34M |
Capital Expenditures | $-3.07M | $-22.91M |
Free Cash Flow | $13.56M | $-47.70M |
Debt Repayment | $-428.38M | $-1.39M |
Common Stock Repurchase | $-1.32M | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ASTH | ARDT |
---|---|---|
Shares Short | 1.55M | 2.04M |
Short Ratio | 4.49 | 7.09 |
Short % of Float | 0.06% | 0.06% |
Average Daily Volume (10 Day) | 324,610 | 336,040 |
Average Daily Volume (90 Day) | 348,273 | 381,800 |
Shares Outstanding | 47.93M | 142.75M |
Float Shares | 37.56M | 33.80M |
% Held by Insiders | 0.22% | 0.23% |
% Held by Institutions | 0.53% | 0.74% |
Dividend Analysis & Yield Comparison: Astrana Health vs Ardent Health
Metric | ASTH | ARDT |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |